JP2005532379A5 - - Google Patents

Download PDF

Info

Publication number
JP2005532379A5
JP2005532379A5 JP2004518566A JP2004518566A JP2005532379A5 JP 2005532379 A5 JP2005532379 A5 JP 2005532379A5 JP 2004518566 A JP2004518566 A JP 2004518566A JP 2004518566 A JP2004518566 A JP 2004518566A JP 2005532379 A5 JP2005532379 A5 JP 2005532379A5
Authority
JP
Japan
Prior art keywords
acid
pharmaceutical composition
inhalable
propellant
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004518566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005532379A (ja
Filing date
Publication date
Priority claimed from DE10230769A external-priority patent/DE10230769A1/de
Application filed filed Critical
Publication of JP2005532379A publication Critical patent/JP2005532379A/ja
Publication of JP2005532379A5 publication Critical patent/JP2005532379A5/ja
Pending legal-status Critical Current

Links

JP2004518566A 2002-07-09 2003-06-25 新規な抗コリン作動薬およびpde−iv阻害剤を基本とする新規な医薬組成物 Pending JP2005532379A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10230769A DE10230769A1 (de) 2002-07-09 2002-07-09 Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
PCT/EP2003/006668 WO2004004704A1 (de) 2002-07-09 2003-06-25 Neue arzneimittelkompositionen auf der basis neuer anticholinergika und pde-iv-inhibitoren

Publications (2)

Publication Number Publication Date
JP2005532379A JP2005532379A (ja) 2005-10-27
JP2005532379A5 true JP2005532379A5 (https=) 2006-08-10

Family

ID=29761758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004518566A Pending JP2005532379A (ja) 2002-07-09 2003-06-25 新規な抗コリン作動薬およびpde−iv阻害剤を基本とする新規な医薬組成物

Country Status (6)

Country Link
EP (1) EP1521576A1 (https=)
JP (1) JP2005532379A (https=)
AU (1) AU2003242755A1 (https=)
CA (1) CA2492026A1 (https=)
DE (1) DE10230769A1 (https=)
WO (1) WO2004004704A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005013967A1 (en) * 2003-07-28 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders
US7071333B2 (en) 2003-07-30 2006-07-04 Bristol-Myers Squibb Company Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
EP1651224B1 (en) * 2003-07-31 2011-10-05 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising an anticholinergic and a betamimetic
CA2547394A1 (en) * 2004-01-09 2005-07-28 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
WO2005074982A2 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
DE102004046235A1 (de) * 2004-09-22 2006-03-30 Altana Pharma Ag Arzneimittelzubereitung
CA2594127C (en) 2005-02-25 2013-10-15 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
EP2484382A1 (en) * 2005-03-30 2012-08-08 Schering Corporation Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020052312A1 (en) * 2000-05-30 2002-05-02 Reiss Theodore F. Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
AR029984A1 (es) * 2000-07-27 2003-07-23 Smithkline Beecham Corp Metodo para reducir las exacerbaciones asociadas copd ambito
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
BR0209992A (pt) * 2001-05-25 2004-04-06 Pfizer Inibidor de pde4 e um agente anticolinérgico em combinação para o tratamento de doenças obstrutivas das vias respiratórias
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method

Similar Documents

Publication Publication Date Title
JP2004521134A5 (https=)
CA2439763A1 (en) Pharmaceutical compositions based on anticholinergics and pde-iv inhibitors
CA2531847C (en) Hfc solution formulations containing an anticholinergic
JP6633497B2 (ja) プロスタグランジンの精製方法
KR100655100B1 (ko) 포르모테롤을 함유하는 저장 가능한 활성 물질 농축물
RS20090083A (sr) Nove vrste kompozicija na bazi jedinjenja koja deluju antiholinergijski i beta-mimetika
CA2481468A1 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
JPH06211651A (ja) 爪白癬治療用組成物
JP2007500676A5 (https=)
JP2005532379A5 (https=)
TWI389692B (zh) 用以吸入β-共效劑的氣溶膠調配物
JP6888180B1 (ja) 抗真菌薬を有効成分とする医薬組成物
US20050026886A1 (en) Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
CA2534120A1 (en) Medicaments for inhalation comprising anticholinergics and a betamimetic
CN102905694B (zh) 吸入溶液
RU2436578C2 (ru) Новые лекарственные комбинации для лечения заболеваний дыхательных путей
JPH04217912A (ja) 水難溶性薬物の医薬組成物
US20120220557A1 (en) Liquid propellant-free formulation comprising an antimuscarinic drug
JP2008506664A (ja) Pdeiv阻害剤とエナンチオマー的に純粋なグリコピロレート塩を含む吸入用薬剤
KR100983208B1 (ko) 티오트로퓸 염을 함유하는 용액의 흡입성 제형
AU2002221738B2 (en) Inhalative solution formulation containing a tiotropium salt
JP2007500149A (ja) 呼吸器系疾患を治療するためのpdeiv阻害剤と抗コリン作用剤を含む薬剤
JP2008542332A (ja) 呼吸器疾患治療用新規医薬組成物
JP2005532379A (ja) 新規な抗コリン作動薬およびpde−iv阻害剤を基本とする新規な医薬組成物
CA2441964A1 (en) New pharmaceutical compositions based on anticholinergics and endothelin antagonists